These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30103254)

  • 1. Radiotherapy for the treatment of distant nodes metastases from oligometastatic urothelial cancer: A retrospective case series.
    Leonetti A; D'Abbiero N; Baldari G; Andreani S; Ruffini L; Viansone AA; Buti S
    Int J Urol; 2018 Oct; 25(10):879-886. PubMed ID: 30103254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent oligometastatic transitional cell bladder carcinoma: is there room for radiotherapy?
    Augugliaro M; Marvaso G; Ciardo D; Zerini D; Riva G; Rondi E; Vigorito S; Comi S; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Neoplasma; 2019 Jan; 66(1):160-165. PubMed ID: 30509099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Body Radiation Therapy in the Management of Oligometastatic and Oligoprogressive Bladder Cancer and Other Urothelial Malignancies.
    Franzese C; Francolini G; Nicosia L; Alongi F; Livi L; Scorsetti M
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):50-56. PubMed ID: 32723486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.
    Yeung R; Hamm J; Liu M; Schellenberg D
    Radiat Oncol; 2017 Jun; 12(1):105. PubMed ID: 28637480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy for mediastinal lymph node with CyberKnife®: Efficacy and toxicity.
    Camps-Malea A; Pointreau Y; Chapet S; Calais G; Barillot I
    Cancer Radiother; 2023 May; 27(3):225-232. PubMed ID: 37080855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences.
    Ost P; Jereczek-Fossa BA; Van As N; Zilli T; Tree A; Henderson D; Orecchia R; Casamassima F; Surgo A; Miralbell R; De Meerleer G
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e115-20. PubMed ID: 27133946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
    Francolini G; Desideri I; Detti B; Di Cataldo V; Masi L; Caramia G; Visani L; Terziani F; Muntoni C; Lo Russo M; Loi M; Livi L
    Cancer Treat Res Commun; 2019; 19():100124. PubMed ID: 30851645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer.
    Jereczek-Fossa BA; Piperno G; Ronchi S; Catalano G; Fodor C; Cambria R; Fossati Ing P; Gherardi F; Alterio D; Zerini D; Garibaldi C; Baroni G; De Cobelli O; Orecchia R
    Am J Clin Oncol; 2014 Jun; 37(3):227-33. PubMed ID: 22992626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic Body Radiotherapy of Lymph Node Oligometastases.
    Burkoň P; Oberreiterová S; Kazda T; Slávik M; Bobek L; Komínek L; Procházka T; Vrzal M; Šlampa P
    Klin Onkol; 2020; 33(2):114-122. PubMed ID: 32303132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis.
    Onal C; Gultekin M; Oymak E; Guler OC; Yilmaz MT; Yuce Sari S; Akkus Yildirim B; Yildiz F
    Int J Gynecol Cancer; 2020 Jun; 30(6):865-872. PubMed ID: 32273293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional control and survival after lymph node SBRT in oligometastatic disease.
    Loi M; Frelinghuysen M; Klass ND; Oomen-De Hoop E; Granton PV; Aerts J; Verhoef C; Nuyttens J
    Clin Exp Metastasis; 2018 Oct; 35(7):625-633. PubMed ID: 29995254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma.
    Franzese C; Franceschini D; Di Brina L; DʼAgostino GR; Navarria P; Comito T; Mancosu P; Tomatis S; Scorsetti M
    J Urol; 2019 Jan; 201(1):70-75. PubMed ID: 30577391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy delivered with IMRT for oligometastatic regional lymph node metastases in hepatocellular carcinoma: a single-institutional study.
    Matoba M; Tsuchiya H; Kondo T; Ota K
    J Radiat Res; 2020 Sep; 61(5):776-783. PubMed ID: 32845298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Fraction Stereotactic Body Radiotherapy for Oligometastatic Lymph Node Relapse in Prostate Cancer.
    Loi M; Di Cataldo V; Francolini G; Bonomo P; Masi L; Simontacchi G; Detti B; Greto D; Desideri I; Livi L
    Oncol Res Treat; 2018; 41(11):703-705. PubMed ID: 30317236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis.
    Nicosia L; Franzese C; Mazzola R; Franceschini D; Rigo M; D'agostino G; Corradini S; Alongi F; Scorsetti M
    Strahlenther Onkol; 2020 Mar; 196(3):213-221. PubMed ID: 31559480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis.
    Ost P; Jereczek-Fossa BA; As NV; Zilli T; Muacevic A; Olivier K; Henderson D; Casamassima F; Orecchia R; Surgo A; Brown L; Tree A; Miralbell R; De Meerleer G
    Eur Urol; 2016 Jan; 69(1):9-12. PubMed ID: 26189689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma.
    Nakagawa T; Kanai Y; Nakanishi H; Komiyama M; Fujimoto H
    Jpn J Clin Oncol; 2012 Nov; 42(11):1066-72. PubMed ID: 22914320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions.
    Inoue T; Katoh N; Aoyama H; Onimaru R; Taguchi H; Onodera S; Yamaguchi S; Shirato H
    Jpn J Clin Oncol; 2010 Aug; 40(8):788-94. PubMed ID: 20406944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive radiotherapy for hilar and/or mediastinal lymph node metastases after stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer: 5-year results.
    Manabe Y; Shibamoto Y; Baba F; Yanagi T; Iwata H; Miyakawa A; Murai T; Okuda K
    Jpn J Radiol; 2018 Dec; 36(12):719-725. PubMed ID: 30218253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Body Radiotherapy for Recurrent or Oligometastatic Uterine Cervix Cancer: A Cooperative Study of the Korean Radiation Oncology Group (KROG 14-11).
    Park HJ; Chang AR; Seo Y; Cho CK; Jang WI; Kim MS; Choi C
    Anticancer Res; 2015 Sep; 35(9):5103-10. PubMed ID: 26254414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.